... attenuated vaccine is recommended for children aged 2 to 17 years. The influenza virus strains in FluMist are ... 6 to 59 months, and for those with a risk factor aged 5 to 17 years. LAIV is not approved for use in children under 2 ...
... invasive breast cancer was considered, and this rose to 17.3% when ductal carcinoma in situ was included.[ 10 ] For ... stronger effects than were found in randomized trials,[ 17 , 18 ] although whether this results from bias, improved ...